SCHEMBL450282

SCHEMBL450282

CCCCCCC(CCCCCCCCCCC(=O)O)OC(C)=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.61
FFAR1 O14842 2/20 0.61
GPR84 Q9NQS5 7/20 0.59
PPARG P37231 7/20 0.59
PPARD Q03181 7/20 0.59
PPARA Q07869 7/20 0.59
HDAC11 Q96DB2 5/20 0.59
TSHR P16473 4/20 0.59
PTPN1 P18031 3/20 0.59
ALDH1A1 P00352 2/20 0.59
TLR2 O60603 2/20 0.59
TDP1 Q9NUW8 2/20 0.59
FABP4 P15090 2/20 0.59
KMT2A Q03164 2/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
MEN1 O00255 1/20 0.59
ESR1 P03372 1/20 0.59
ALOX15 P16050 1/20 0.59
PDE4A P27815 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23288411 1.00 FFAR4 (0.61) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL2483044 1.00 FFAR4 (0.61) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL17332277 1.00 FFAR4 (0.61) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL2482140 1.00 FFAR4 (0.61) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL23288472 0.98 FFAR4 (0.59) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL17332267 0.97 FFAR4 (0.56) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL25189818 0.97 FFAR4 (0.56) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL25186863 0.95 FFAR4 (0.53) FFAR4FFAR1GPR84PPARGPPARD
Stearic Acid SCHEMBL27950735 0.93 FFAR4 (0.57) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL25187492 0.93 FFAR4 (0.51) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1961303-B1 MICROENCAPSULATED PESTICIDE SUMITOMO CHEMICAL CO (JP) 2014-10-01 EP claimed
EP-1283704-B1 PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF ANTI-INFLAMMATORY AGENTS SANOFI SA (FR) 2013-12-18 EP claimed
US-20090142406-A1 Microencapsulated Pesticide SUMITOMO CHEMICSL COMAPNY, LIMITED 2009-06-04 US claimed
EP-1961303-A1 MICROENCAPSULATED PESTICIDE Sumitomo Chemical Company, Limited (JP) 2008-08-27 EP claimed
EP-0817621-B2 PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY SANOFI AVENTIS (FR) 2007-12-26 EP claimed
EP-1283704-A2 PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF ANTI-INFLAMMATORY AGENTS Sanofi-Aventis (FR) 2003-02-19 EP claimed
WO-2001085143-A2 PHARMACEUTICAL COMPOSITIONS FOR TRANSDERMAL ADMINISTRATION OF ANTI-INFLAMMATORY AGENTS SANOFI-SYNTHELABO (FR) 2001-11-15 WO claimed
EP-0817621-B1 PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY SANOFI SYNTHELABO (FR) 2001-06-20 EP claimed
EP-0817621-A1 PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY SANOFI (FR) 1998-01-14 EP claimed
WO-1996030000-A1 PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY SANOFI (FR) 1996-10-03 WO claimed
JP-59001534-A None JP disclosed
CN-117024917-A Composite, molded article, and cured product 株式会社力森诺科 2023-11-10 CN disclosed
CN-113906091-B Composite, molded article, and cured product 株式会社力森诺科 2023-09-19 CN disclosed
CN-113906091-A Composite, molded article, and cured article 昭和电工材料株式会社 2022-01-07 CN disclosed
US-10350569-B2 Method for producing microcapsule SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-16 US disclosed
US-5173389-A Polyhydroxy material reacted with 1,2-naphthoquinonediazide-4 or 5-sulfonyl chloride; novolak binder FUJI PHOTO FILM CO., LTD. (JP) 1992-12-22 US disclosed
EP-0395049-A1 Positive-working photoresist composition FUJI PHOTO FILM CO., LTD. (JP) 1990-10-31 EP disclosed
US-4913799-A INCREASING OCTANE NUMBER OF CRACKED PRODUCT UOP (US) 1990-04-03 US disclosed
JP-S591534-A ETCHANT FOR POLYIMIDE RESIN HITACHI LTD 1984-01-06 JP disclosed
US-4083816-A Acetoxymethyl derivatives of polyunsaturated fatty triglycerides as primary plasticizers for polyvinylchloride THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10350569-B2 Method for producing microcapsule MCCC2, ACAT2, SRM FFAR4 255/4885FFAR1 132/4885GPR84 2449/4885
US-20090142406-A1 Microencapsulated Pesticide CHRM2, CHRM1, CHRM5 FFAR4 28/4885FFAR1 12/4885GPR84 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.